¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ J+d1&Tw&  
OO[F E3F  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© b[V^86X^  
Xd^\@  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© y WV#Up  
yR(x+ Gs{]  
1.Co-stimulators (or co-stimulating molecules)  Yn8=  
g=I8@m  
2.NK-kB (?nCy HC%g  
`ZC<W]WYX/  
3.Immunoglobulin superfamily x c{hC4^V  
M(/r%-D  
4.antigen-presenting cell (APC) As>_J=8} 3  
%2v4<icvq  
5.death domain 0jEL<TgC  
M![J2 =  
6.CCR and CXCR &RfC"lc  
e=.]F *:J  
7.Lectin (or mitogen) H)n9O/u  
K.0: C`C  
8.Clusters of differentiation, CD) E~6c- Lw  
A{A\RSZ0  
9.B7 family [UH||qW  
0=?<y'=  
10.Cytotoxic T lymphocyte, CTL) >rf'-X4n  
=uS9JU^E  
11.IL-15 and IL-15 receptor (IL-15R) OynXkH]0T+  
pS:4CNI{  
12.MHC restriction -PfX0y9n  
s=;uc] 9g  
13.Affinity-chromatography Fx2bwut.K  
3eF -8Z(f  
14.Cyctosprin A, CsA P(f0R8BE  
H5Io{B%=  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) =o$sxb E(  
tIuCct-  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© BW$"`T@c6~  
i uF*.hc,%  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 '2 PF  
{y_98N  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ]d! UJ&<?  
Q|#W#LV,K  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ & tg&5_  
 PoxK{Y  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© (pv+c,  
*GL/aEI<$  
ÃâÒßѧרҵ£º 2#c<\s|C  
d?A 0MKnl  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ s~5[![1 K  
z=q3Zo   
Ïû»¯ÄÚ¿Æ£º wk5s)%V  
)b)-ZS7  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ b4[bL2J$h1  
/`wvxKX  
ѪҺ²¡Ñ§×¨Òµ£º onz?_SAW  
`p2+&&]S  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»